期刊文献+

(±)-3-氨甲基-5-甲基己酸的合成

Synthesis of(±)-3-Aminomethyl-5-methylhexanoic Acid
原文传递
导出
摘要 本研究对普瑞巴林的重要中间体(±)-3-氨甲基-5-甲基己酸的合成工艺进行改进。丙二酸与异戊醛缩合后,再经酯化得5-甲基-2-己烯酸乙酯(3)。3 空间位阻小,易于与丙二酸二乙酯发生加成反应。加成反应后直接水解得3-异丁基戊二酸,再经脱水和氨解得(±)-3-氨甲酰甲基-5-甲基己酸,最后经Hofmann 重排得目标物,总收率60.3%。本工艺在优化Hofmann 重排时发现,反应温度对收率影响较大。加入次溴酸钠后,反应温度会升高至75~85℃,此时不可干预降温,应保持该温度使其自行降温,然后再加热至80~85℃反应2 h,收率高(88%)。本工艺操作简便、总收率高(60.3%),已通过中试验证。 The synthetic process of (±)-3-aminomethyl-5-methylhexanoic acid, an important intermediate of pregabalin, was improved. Malonic acid was subjected to a condensation with isovaleraldehyde and a esterification to give ethyl 5-methyl-2-hexenoate(3). Due to the small steric hindrance of 3, it was easy to carry out the addition with diethyl malonate, which was followed by a hydrolysis directly to afford 3-isobutylpentanedioic acid. Then, the latter was subjected to dehydration, ammonia hydrolysis, and Hofmann rearrangement to prepare the target compound with a total yield of 60.3%. When the Hofmann rearrangement was optimized, it was found that the reaction temperature had a great influence on the yield. When sodium hypobromite was added, the reaction temperature gone up to 75-85 ℃. Then, the temperature should be maintained and be lowered by itself. And then, the reaction temperature was raised again to 80-85 ℃ for 2 hours, a high yield(88%) was obtained for the target compound. This process was simple to operate and has high yield, and it has been tested in pilot scale.
作者 陈文华 祁秀秀 尤海烽 CHEN Wenhua;QI Xiuxiu;YOU Haifeng(Dept. of Pharmaceutical and Biotechnology, Changzhou Vocation College of Engineering and Technology, Changzhou 213164)
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2019年第7期746-748,共3页 Chinese Journal of Pharmaceuticals
关键词 普瑞巴林 中间体 (±)-3-氨甲基-5-甲基己酸 丙二酸 Hofmann重排 pregabalin intermediate (±)-3-aminomethyl-5-methylhexanoic acid malonic acid Hofmann rearrangement
  • 相关文献

参考文献3

二级参考文献13

  • 1李晓东,须媚.GABA受体激动剂 普瑞巴林(pregabalin)[J].世界临床药物,2006,27(3):186-187. 被引量:7
  • 2[1]Anonymous. Pregabalin [J]. Drugs Future, 1999, 24 (8): 862-870.
  • 3[2]Yuen PW, Kanter GD, Taylor CP, et al. Enantioselective synthesis of PD 144723: a potent stereospecific anticonvulsant [J].Bioorg Med Chem Lett, 1994, 4(6): 823-826.
  • 4[3]Hoekstra MS, Sobieray DM, Schwindt MA, et al. Chemical development of CI-1008, an enantiomerically pure anticonvulsant [J]. Org Process Res Dev, 1997, 1 (1): 26-38.
  • 5[4]Grote TM, Huckabee BK, Mulhern T, et al. Method of making (S) -3- (aminomethyl) -5-methylhexanoic acid [P]. WO:9640617, 1996-12-19. (CA 1997, 126: 104423)
  • 6[5]Huckabee BK, Sobieray DM. Stereoselective synthesis of (S)-3- (aminomethyl)-5-methylhexanoic acid [P] . WO:9638405, 1996-12-05. (CA 1997, 126: 131188)
  • 7YUEN P, KANTER G D, TAYLOR C P, et al. Enantioselective synthesis of PD144723:a potent stereospecific anticonvulsant[J]. Bioorg Med Chem Lett, 1994,4(6):823 - 826.
  • 8HOEKSTRA M S, SOBIERAY D M, SCHWINDT M A, et al. Chemcal development of CI-1008, an enaniomerically pure anticonvulsant [ J ]. Org Process Res Dev, 1997,1(1):26 - 38.
  • 9HUCKABEE B K, SOBIERAY D M. Stereoselective synthesis of ( S )-3-( aminomethyl )-5-methylhexanoic acid.WO, 1996/38405[P]. 1996- 12- 05.
  • 10GROTE T M, HUCKABEE B K, MULHEM T, et al.Method of making ( S )-3-( aminomethyl )-5-methylhexanoic acid:WO, 1996/40617[P]. 1996- 12- 19.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部